18,95 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
  • Broschiertes Buch

Seminar paper from the year 2023 in the subject Business economics - Miscellaneous, grade: 1,0, Fachhochschule des bfi Wien GmbH (MBA Digital Transformation), course: Neue Arbeitswelt, language: English, abstract: Pharmaceutical production is a field of work characterized by extensive regulations. The entire range of digital technologies is used today to optimize traditional business practices. This seminar paper describes the adoption of future working principles for the rapidly developing digital technologies and applications. The research questions address the introduction of new scientific…mehr

Produktbeschreibung
Seminar paper from the year 2023 in the subject Business economics - Miscellaneous, grade: 1,0, Fachhochschule des bfi Wien GmbH (MBA Digital Transformation), course: Neue Arbeitswelt, language: English, abstract: Pharmaceutical production is a field of work characterized by extensive regulations. The entire range of digital technologies is used today to optimize traditional business practices. This seminar paper describes the adoption of future working principles for the rapidly developing digital technologies and applications. The research questions address the introduction of new scientific and digital working methods in the strictly regulated pharmaceutical production environment. They are answered on the basis of a literature analysis to show the impact on production systems, work personnel and the relationship with regulatory authorities. The future of work in pharmaceutical production will be distinguished by autonomous processes that almost eliminate manual work and human supervision. Cooperation with regulatory authorities will develop into mutual dialogue-oriented communication and continuous data exchange.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Dr. Hans-Walter Höhl offers consulting services as an independent freelancer for international companies and expert networks in the areas of pharmaceutical manufacturing, supply chains and their digital transformation. After joining Bayer in 1980, Dr. Höhl developed a broad background in divisions and central functions, where he led engineering positions in process development for active ingredients and polymers. He later joined the division Pharmaceuticals, where he held leading positions in international operations, supply chain management, manufacturing strategy, operational excellence and digitalization. In his last role, he was responsible for defining the manufacturing strategy and executing the digital transformation at key sites and functions. The corresponding digital roadmap was based on the experience gained at a pilot site in Italy, which was recognized by the World Economic Forum as a digital lighthouse factory in 2019. He retired in 2020. Dr. Höhl received his diploma and doctorate in process engineering from the Technical University of Braunschweig, Germany. In 2024, he earned an MBA in Digital Transformation from the University of Applied Sciences BFI Vienna, Austria.